5-[1-[4-(dimethylamino)piperidin-1-yl]ethyl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-2-(1-methylimidazol-2-yl)indolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-2-(1-ethylimidazol-2-yl)-6-methyl-5-(1-morpholin-4-ylethyl)indolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-2-(1H-imidazol-2-yl)-6-methyl-5-(1-morpholin-4-ylethyl)indolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-5-(1-morpholin-4-ylethyl)-2-[3-(morpholin-4-ylmethyl)phenyl]indolizine-7-carboxamide

C122H152N24O12 — CID 158016820

IUPAC5-[1-[4-(dimethylamino)piperidin-1-yl]ethyl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-2-(1-methylimidazol-2-yl)indolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-2-(1-ethylimidazol-2-yl)-6-methyl-5-(1-morpholin-4-ylethyl)indolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-2-(1H-imidazol-2-yl)-6-methyl-5-(1-morpholin-4-ylethyl)indolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-5-(1-morpholin-4-ylethyl)-2-[3-(morpholin-4-ylmethyl)phenyl]indolizine-7-carboxamide
SMILESCCn1ccnc1-c1cc2cc(C(=O)NCc3c(C)cc(C)[nH]c3=O)c(C)c(C(C)N3CCOCC3)n2c1.Cc1cc(C)c(CNC(=O)c2cc3cc(-c4cccc(CN5CCOCC5)c4)cn3c(C(C)N3CCOCC3)c2C)c(=O)[nH]1.Cc1cc(C)c(CNC(=O)c2cc3cc(-c4ncc[nH]4)cn3c(C(C)N3CCOCC3)c2C)c(=O)[nH]1.Cc1cc(C)c(CNC(=O)c2cc3cc(-c4nccn4C)cn3c(C(C)N3CCC(N(C)C)CC3)c2C)c(=O)[nH]1
InChIInChI=1S/C35H43N5O4.C31H41N7O2.C29H36N6O3.C27H32N6O3/c1-23-16-24(2)37-35(42)32(23)20-36-34(41)31-19-30-18-29(28-7-5-6-27(17-28)21-38-8-12-43-13-9-38)22-40(30)33(25(31)3)26(4)39-10-14-44-15-11-39;1-19-14-20(2)34-31(40)27(19)17-33-30(39)26-16-25-15-23(29-32-10-13-36(29)7)18-38(25)28(21(26)3)22(4)37-11-8-24(9-12-37)35(5)6;1-6-33-8-7-30-27(33)22-14-23-15-24(28(36)31-16-25-18(2)13-19(3)32-29(25)37)20(4)26(35(23)17-22)21(5)34-9-11-38-12-10-34;1-16-11-17(2)31-27(35)23(16)14-30-26(34)22-13-21-12-20(25-28-5-6-29-25)15-33(21)24(18(22)3)19(4)32-7-9-36-10-8-32/h5-7,16-19,22,26H,8-15,20-21H2,1-4H3,(H,36,41)(H,37,42);10,13-16,18,22,24H,8-9,11-12,17H2,1-7H3,(H,33,39)(H,34,40);7-8,13-15,17,21H,6,9-12,16H2,1-5H3,(H,31,36)(H,32,37);5-6,11-13,15,19H,7-10,14H2,1-4H3,(H,28,29)(H,30,34)(H,31,35)
InChIKeyFFOOXDALALBCRF-UHFFFAOYSA-N
MW2146.71 g/mol
LogP15.37
Rot. Bonds28

About 5-[1-[4-(dimethylamino)piperidin-1-yl]ethyl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-2-(1-methylimidazol-2-yl)indolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-2-(1-ethylimidazol-2-yl)-6-methyl-5-(1-morpholin-4-ylethyl)indolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-2-(1H-imidazol-2-yl)-6-methyl-5-(1-morpholin-4-ylethyl)indolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-5-(1-morpholin-4-ylethyl)-2-[3-(morpholin-4-ylmethyl)phenyl]indolizine-7-carboxamide

5-[1-[4-(dimethylamino)piperidin-1-yl]ethyl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-2-(1-methylimidazol-2-yl)indolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-2-(1-ethylimidazol-2-yl)-6-methyl-5-(1-morpholin-4-ylethyl)indolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-2-(1H-imidazol-2-yl)-6-methyl-5-(1-morpholin-4-ylethyl)indolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-5-(1-morpholin-4-ylethyl)-2-[3-(morpholin-4-ylmethyl)phenyl]indolizine-7-carboxamide (PubChem CID 158016820) has the molecular formula C122H152N24O12 and a molecular weight of 2146.71 g/mol. Its IUPAC name is 5-[1-[4-(dimethylamino)piperidin-1-yl]ethyl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-2-(1-methylimidazol-2-yl)indolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-2-(1-ethylimidazol-2-yl)-6-methyl-5-(1-morpholin-4-ylethyl)indolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-2-(1H-imidazol-2-yl)-6-methyl-5-(1-morpholin-4-ylethyl)indolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-5-(1-morpholin-4-ylethyl)-2-[3-(morpholin-4-ylmethyl)phenyl]indolizine-7-carboxamide.

Molecular Properties

Compound Name5-[1-[4-(dimethylamino)piperidin-1-yl]ethyl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-2-(1-methylimidazol-2-yl)indolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-2-(1-ethylimidazol-2-yl)-6-methyl-5-(1-morpholin-4-ylethyl)indolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-2-(1H-imidazol-2-yl)-6-methyl-5-(1-morpholin-4-ylethyl)indolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-5-(1-morpholin-4-ylethyl)-2-[3-(morpholin-4-ylmethyl)phenyl]indolizine-7-carboxamide
PubChem CID158016820
Molecular FormulaC122H152N24O12
Molecular Weight2146.71 g/mol
Exact Mass2145.20
IUPAC Name5-[1-[4-(dimethylamino)piperidin-1-yl]ethyl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-2-(1-methylimidazol-2-yl)indolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-2-(1-ethylimidazol-2-yl)-6-methyl-5-(1-morpholin-4-ylethyl)indolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-2-(1H-imidazol-2-yl)-6-methyl-5-(1-morpholin-4-ylethyl)indolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-5-(1-morpholin-4-ylethyl)-2-[3-(morpholin-4-ylmethyl)phenyl]indolizine-7-carboxamide
SMILESCCn1ccnc1-c1cc2cc(C(=O)NCc3c(C)cc(C)[nH]c3=O)c(C)c(C(C)N3CCOCC3)n2c1.Cc1cc(C)c(CNC(=O)c2cc3cc(-c4cccc(CN5CCOCC5)c4)cn3c(C(C)N3CCOCC3)c2C)c(=O)[nH]1.Cc1cc(C)c(CNC(=O)c2cc3cc(-c4ncc[nH]4)cn3c(C(C)N3CCOCC3)c2C)c(=O)[nH]1.Cc1cc(C)c(CNC(=O)c2cc3cc(-c4nccn4C)cn3c(C(C)N3CCC(N(C)C)CC3)c2C)c(=O)[nH]1
InChIInChI=1S/C35H43N5O4.C31H41N7O2.C29H36N6O3.C27H32N6O3/c1-23-16-24(2)37-35(42)32(23)20-36-34(41)31-19-30-18-29(28-7-5-6-27(17-28)21-38-8-12-43-13-9-38)22-40(30)33(25(31)3)26(4)39-10-14-44-15-11-39;1-19-14-20(2)34-31(40)27(19)17-33-30(39)26-16-25-15-23(29-32-10-13-36(29)7)18-38(25)28(21(26)3)22(4)37-11-8-24(9-12-37)35(5)6;1-6-33-8-7-30-27(33)22-14-23-15-24(28(36)31-16-25-18(2)13-19(3)32-29(25)37)20(4)26(35(23)17-22)21(5)34-9-11-38-12-10-34;1-16-11-17(2)31-27(35)23(16)14-30-26(34)22-13-21-12-20(25-28-5-6-29-25)15-33(21)24(18(22)3)19(4)32-7-9-36-10-8-32/h5-7,16-19,22,26H,8-15,20-21H2,1-4H3,(H,36,41)(H,37,42);10,13-16,18,22,24H,8-9,11-12,17H2,1-7H3,(H,33,39)(H,34,40);7-8,13-15,17,21H,6,9-12,16H2,1-5H3,(H,31,36)(H,32,37);5-6,11-13,15,19H,7-10,14H2,1-4H3,(H,28,29)(H,30,34)(H,31,35)
InChIKeyFFOOXDALALBCRF-UHFFFAOYSA-N
XLogP15.37
TPSA386.16 Ų
H-Bond Donors9
H-Bond Acceptors27
Rotatable Bonds28
Heavy Atoms158
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002146.71
LogP ≤ 515.37
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1027

Analyze 5-[1-[4-(dimethylamino)piperidin-1-yl]ethyl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-2-(1-methylimidazol-2-yl)indolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-2-(1-ethylimidazol-2-yl)-6-methyl-5-(1-morpholin-4-ylethyl)indolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-2-(1H-imidazol-2-yl)-6-methyl-5-(1-morpholin-4-ylethyl)indolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-5-(1-morpholin-4-ylethyl)-2-[3-(morpholin-4-ylmethyl)phenyl]indolizine-7-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

4-(7-Methylimidazo [1,2-a]pyridin-3-yl)-7-[(5-morpholino-2-pyridyl)amino 1-2,3-dihydropyrrolo [3,4-c]pyridin-1-one
CID 156163413
2-[1-[3-[(dimethylamino)methyl]phenyl]imidazol-4-yl]-N-[(4,6-dimethyl-2-oxopiperidin-3-yl)methyl]-6-methyl-5-(1-morpholin-4-ylethyl)indolizine-7-carboxamide
CID 156907528
2-[1-[4-[(dimethylamino)methyl]phenyl]imidazol-4-yl]-N-[(4,6-dimethyl-2-oxopiperidin-3-yl)methyl]-6-methyl-5-(1-morpholin-4-ylethyl)indolizine-7-carboxamide
CID 156907529
N-[(4,6-dimethyl-2-oxo-3H-pyridin-3-yl)methyl]-6-methyl-2-(1-methylimidazol-2-yl)-5-(1-morpholin-4-ylethyl)indolizine-7-carboxamide
CID 156907533
N-[(4,6-dimethyl-2-oxo-3H-pyridin-3-yl)methyl]-6-methyl-2-(3-methylimidazol-4-yl)-5-(1-morpholin-4-ylethyl)indolizine-7-carboxamide
CID 156907539
N-[(4,6-dimethyl-2-oxopiperidin-3-yl)methyl]-2-(1H-imidazol-2-yl)-6-methyl-5-(1-morpholin-4-ylethyl)indolizine-7-carboxamide
CID 156907564
4-(3H-benzimidazol-5-yl)-1-methyl-N-[1-methyl-5-[[1-methyl-5-(2-morpholin-4-ylethylcarbamoyl)pyrrol-3-yl]carbamoyl]pyrrol-3-yl]pyrrole-2-carboxamide
CID 44351124
2-methyl-1-[5-[3-[(2-methyl-3H-benzimidazole-5-carbonyl)amino]phenyl]-2-pyridinyl]-N-(3-morpholin-4-ylpropyl)benzimidazole-5-carboxamide
CID 137639511
US10994015, Example 87
CID 156905968
US10994015, Example 288
CID 156906005
[3-(12-Fluoro-4-pyridin-3-yl-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(13),2,4,6,9,11-hexaen-13-yl)phenyl]-morpholin-4-ylmethanone
CID 68169978
1-[1-[[9-ethyl-2-(5-fluoroindol-1-yl)-6-morpholin-4-ylpurin-8-yl]methyl]piperidin-4-yl]-4-[[[1-[[2-(1H-indol-3-yl)-9-methyl-6-morpholin-4-ylpurin-8-yl]methyl]piperidin-4-yl]-methylamino]methyl]pyrrolidin-2-one
CID 90775981

Frequently Asked Questions

What is the IUPAC name of 5-[1-[4-(dimethylamino)piperidin-1-yl]ethyl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-2-(1-methylimidazol-2-yl)indolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-2-(1-ethylimidazol-2-yl)-6-methyl-5-(1-morpholin-4-ylethyl)indolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-2-(1H-imidazol-2-yl)-6-methyl-5-(1-morpholin-4-ylethyl)indolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-5-(1-morpholin-4-ylethyl)-2-[3-(morpholin-4-ylmethyl)phenyl]indolizine-7-carboxamide?
The IUPAC name of 5-[1-[4-(dimethylamino)piperidin-1-yl]ethyl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-2-(1-methylimidazol-2-yl)indolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-2-(1-ethylimidazol-2-yl)-6-methyl-5-(1-morpholin-4-ylethyl)indolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-2-(1H-imidazol-2-yl)-6-methyl-5-(1-morpholin-4-ylethyl)indolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-5-(1-morpholin-4-ylethyl)-2-[3-(morpholin-4-ylmethyl)phenyl]indolizine-7-carboxamide (CID 158016820) is 5-[1-[4-(dimethylamino)piperidin-1-yl]ethyl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-2-(1-methylimidazol-2-yl)indolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-2-(1-ethylimidazol-2-yl)-6-methyl-5-(1-morpholin-4-ylethyl)indolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-2-(1H-imidazol-2-yl)-6-methyl-5-(1-morpholin-4-ylethyl)indolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-5-(1-morpholin-4-ylethyl)-2-[3-(morpholin-4-ylmethyl)phenyl]indolizine-7-carboxamide.
What is the SMILES notation for 5-[1-[4-(dimethylamino)piperidin-1-yl]ethyl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-2-(1-methylimidazol-2-yl)indolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-2-(1-ethylimidazol-2-yl)-6-methyl-5-(1-morpholin-4-ylethyl)indolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-2-(1H-imidazol-2-yl)-6-methyl-5-(1-morpholin-4-ylethyl)indolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-5-(1-morpholin-4-ylethyl)-2-[3-(morpholin-4-ylmethyl)phenyl]indolizine-7-carboxamide?
The canonical SMILES for 5-[1-[4-(dimethylamino)piperidin-1-yl]ethyl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-2-(1-methylimidazol-2-yl)indolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-2-(1-ethylimidazol-2-yl)-6-methyl-5-(1-morpholin-4-ylethyl)indolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-2-(1H-imidazol-2-yl)-6-methyl-5-(1-morpholin-4-ylethyl)indolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-5-(1-morpholin-4-ylethyl)-2-[3-(morpholin-4-ylmethyl)phenyl]indolizine-7-carboxamide is CCn1ccnc1-c1cc2cc(C(=O)NCc3c(C)cc(C)[nH]c3=O)c(C)c(C(C)N3CCOCC3)n2c1.Cc1cc(C)c(CNC(=O)c2cc3cc(-c4cccc(CN5CCOCC5)c4)cn3c(C(C)N3CCOCC3)c2C)c(=O)[nH]1.Cc1cc(C)c(CNC(=O)c2cc3cc(-c4ncc[nH]4)cn3c(C(C)N3CCOCC3)c2C)c(=O)[nH]1.Cc1cc(C)c(CNC(=O)c2cc3cc(-c4nccn4C)cn3c(C(C)N3CCC(N(C)C)CC3)c2C)c(=O)[nH]1.
What is the InChIKey of 5-[1-[4-(dimethylamino)piperidin-1-yl]ethyl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-2-(1-methylimidazol-2-yl)indolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-2-(1-ethylimidazol-2-yl)-6-methyl-5-(1-morpholin-4-ylethyl)indolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-2-(1H-imidazol-2-yl)-6-methyl-5-(1-morpholin-4-ylethyl)indolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-5-(1-morpholin-4-ylethyl)-2-[3-(morpholin-4-ylmethyl)phenyl]indolizine-7-carboxamide?
The InChIKey is FFOOXDALALBCRF-UHFFFAOYSA-N. The full InChI is InChI=1S/C35H43N5O4.C31H41N7O2.C29H36N6O3.C27H32N6O3/c1-23-16-24(2)37-35(42)32(23)20-36-34(41)31-19-30-18-29(28-7-5-6-27(17-28)21-38-8-12-43-13-9-38)22-40(30)33(25(31)3)26(4)39-10-14-44-15-11-39;1-19-14-20(2)34-31(40)27(19)17-33-30(39)26-16-25-15-23(29-32-10-13-36(29)7)18-38(25)28(21(26)3)22(4)37-11-8-24(9-12-37)35(5)6;1-6-33-8-7-30-27(33)22-14-23-15-24(28(36)31-16-25-18(2)13-19(3)32-29(25)37)20(4)26(35(23)17-22)21(5)34-9-11-38-12-10-34;1-16-11-17(2)31-27(35)23(16)14-30-26(34)22-13-21-12-20(25-28-5-6-29-25)15-33(21)24(18(22)3)19(4)32-7-9-36-10-8-32/h5-7,16-19,22,26H,8-15,20-21H2,1-4H3,(H,36,41)(H,37,42);10,13-16,18,22,24H,8-9,11-12,17H2,1-7H3,(H,33,39)(H,34,40);7-8,13-15,17,21H,6,9-12,16H2,1-5H3,(H,31,36)(H,32,37);5-6,11-13,15,19H,7-10,14H2,1-4H3,(H,28,29)(H,30,34)(H,31,35).
What are the key properties of 5-[1-[4-(dimethylamino)piperidin-1-yl]ethyl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-2-(1-methylimidazol-2-yl)indolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-2-(1-ethylimidazol-2-yl)-6-methyl-5-(1-morpholin-4-ylethyl)indolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-2-(1H-imidazol-2-yl)-6-methyl-5-(1-morpholin-4-ylethyl)indolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-5-(1-morpholin-4-ylethyl)-2-[3-(morpholin-4-ylmethyl)phenyl]indolizine-7-carboxamide?
5-[1-[4-(dimethylamino)piperidin-1-yl]ethyl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-2-(1-methylimidazol-2-yl)indolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-2-(1-ethylimidazol-2-yl)-6-methyl-5-(1-morpholin-4-ylethyl)indolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-2-(1H-imidazol-2-yl)-6-methyl-5-(1-morpholin-4-ylethyl)indolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-5-(1-morpholin-4-ylethyl)-2-[3-(morpholin-4-ylmethyl)phenyl]indolizine-7-carboxamide has a molecular weight of 2146.71 g/mol, XLogP of 15.37, 28 rotatable bonds, 9 hydrogen bond donors, and 27 hydrogen bond acceptors.
Where does this data come from?
All data for 5-[1-[4-(dimethylamino)piperidin-1-yl]ethyl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-2-(1-methylimidazol-2-yl)indolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-2-(1-ethylimidazol-2-yl)-6-methyl-5-(1-morpholin-4-ylethyl)indolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-2-(1H-imidazol-2-yl)-6-methyl-5-(1-morpholin-4-ylethyl)indolizine-7-carboxamide;N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-5-(1-morpholin-4-ylethyl)-2-[3-(morpholin-4-ylmethyl)phenyl]indolizine-7-carboxamide is sourced from PubChem (CID 158016820), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).